Newsfile
Search documents
Sun Summit Announces Upsized Non-Brokered Private Placement of up to $11.5 Million
Newsfile· 2025-12-12 22:01
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - Sun Summit Minerals Corp. (TSXV: SMN) (OTCQB: SMREF) ("Sun Summit" or the "Company") is pleased to announce that, due to significant investor demand, it has increased the maximum gross proceeds of its previously announced non-brokered private placement (the "Private Placement") from $7 million to $11.5 million. The Private Placement includes a combination of: (i) charity flow-through common shares in the capital of the Company (each, a "Ch ...
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
Newsfile· 2025-12-12 22:00
Core Viewpoint - Theralase® Technologies Inc. has initiated a non-brokered private placement to raise up to $CAN 2,000,000 for advancing its clinical studies and working capital needs [1][3]. Group 1: Offering Details - The private placement consists of units priced at $CAN 0.17, each unit includes one common share and one warrant [2]. - Each warrant allows the holder to purchase one common share at an exercise price of $CAN 0.21 for 60 months following the closing date [2]. - The offering is expected to close around the week of December 15, 2025, pending necessary approvals [4]. Group 2: Use of Proceeds - Proceeds from the offering will be utilized to further the Phase II Non-Muscle Invasive Bladder Cancer clinical study and for general working capital [3]. Group 3: Regulatory and Compliance - The offering is available to accredited investors in Canada and U.S. persons under specific exemptions from registration requirements [5]. - All securities issued will be subject to a hold period of four months and one day from the closing date [3]. Group 4: Finder's Fees - The company will pay a finder's fee of 7% of gross proceeds and issue non-transferable finder warrants equal to 7% of the total units issued [6]. Group 5: Company Overview - Theralase® is a clinical stage pharmaceutical company focused on developing light, radiation, sound, and drug-activated therapeutics for treating cancer, bacteria, and viruses [9].
MultiSensor AI Holdings, Inc. Announces Postponement of Special Meeting of Stockholders to December 19, 2025
Newsfile· 2025-12-12 21:59
Core Viewpoint - MultiSensor AI Holdings, Inc. has postponed its special meeting of stockholders from December 15, 2025, to December 19, 2025, while maintaining the same proposals for voting [1][3]. Company Information - MultiSensor AI Holdings, Inc. specializes in AI-powered industrial condition-based maintenance and process control solutions, utilizing intelligent multi-sensing platforms that integrate edge and cloud software [5]. - The company's solutions leverage data from various sensors, including thermal imagers, visible and acoustic imagers, vibration, and laser spectroscopy sensors, aimed at protecting critical assets and minimizing unplanned downtime [5].
Paradigm Gold Closes Non-Brokered Private Placement
Newsfile· 2025-12-12 21:30
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - Paradigm Gold Corporation (TSXV: PDQ) ("Paradigm" or the "Company") has closed the second tranche of its previously announced non-brokered private placement (the "Offering") raising a total of $190,000.In this second tranche, the Company issued 400,000 non-flow-through units ("NFT Units") at a price of $0.10 per NFT Unit for gross proceeds of $40,000. In the first tranche, the Company issued 1,500,000 NFT Units for gross proceeds of $150,0 ...
RZLT INVESTIGATION: Rezolute, Inc. Investors Should Contact Block & Leviton LLP To Potentially Recover Losses
Newsfile· 2025-12-12 20:00
Core Viewpoint - Rezolute, Inc. (NASDAQ: RZLT) experienced a significant decline in share price, falling over 85% after the failure of its Phase 3 sunRIZE study in congenital hyperinsulinism, which did not meet its primary or key secondary endpoints. This has raised concerns about potential securities law violations due to misleading statements made by the company regarding earlier data and program outlook [2][4]. Group 1: Company Performance - The share price of Rezolute, Inc. dropped more than 85% on December 11, 2025, following the announcement of the failed clinical trial results [2]. - The Phase 3 sunRIZE study aimed at treating congenital hyperinsulinism did not achieve its primary or key secondary endpoints, leading to investor losses [2]. Group 2: Legal Investigation - Block & Leviton is investigating Rezolute, Inc. for potential securities law violations and may file an action to recover losses for affected investors [4]. - Investors who purchased common stock in Rezolute, Inc. and experienced a decline in share value may be eligible to participate in the investigation, regardless of whether they sold their shares [3]. Group 3: Investor Support - Block & Leviton encourages investors who have lost money to contact them for assistance in recovering losses [5]. - The firm is recognized as a leading securities class action firm, having recovered billions for defrauded investors through litigation [7].
Spark Energy Minerals Announces Closing of Private Placement
Newsfile· 2025-12-12 19:51
Core Viewpoint - Spark Energy Minerals Inc. has successfully closed a non-brokered private placement, raising gross proceeds of $500,000 through the issuance of 10,000,000 units, which will support its exploration initiatives in Brazil [1][2]. Group 1: Private Placement Details - The private placement was fully subscribed by a strategic investor, enhancing Spark's shareholder base and aligning interests in the company's exploration efforts [2]. - Each unit consists of one common share and one common share purchase warrant, with warrants exercisable at $0.06 for three years [3]. - The net proceeds will fund the near-term drill program at the Arapaima Project in Brazil, covering mobilization and initial drilling costs, with remaining funds allocated to general working capital [4]. Group 2: Company Overview - Spark Energy Minerals Inc. focuses on the exploration and development of critical minerals essential for the clean-energy transition, particularly in Brazil's Lithium Valley [7]. - The Arapaima Project spans approximately 91,900 hectares and targets lithium and gallium-REE mineralization, contributing to a sustainable supply chain for electrification and renewable energy [7].
MLTX DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX
Newsfile· 2025-12-12 19:12
Core Viewpoint - Rosen Law Firm is encouraging investors of MoonLake Immunotherapeutics who incurred losses exceeding $100,000 during the specified class period to secure legal counsel before the December 15, 2025 deadline for a securities class action [1]. Group 1: Class Action Details - Investors who purchased MoonLake common stock between March 10, 2024, and September 29, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 15, 2025 deadline to serve as lead plaintiff, representing other class members in the litigation [3]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a proven track record in securities class actions, highlighting their own achievements in recovering significant settlements for investors [4]. - The firm has been recognized for its success in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and recovering over $438 million for investors in 2019 [4]. Group 3: Case Allegations - The complaint alleges that during the class period, defendants made false or misleading statements regarding the efficacy of MoonLake's Nanobodies compared to traditional monoclonal antibodies, leading to investor losses when the truth was revealed [5].
Kingsmen Engages Resource Stock Digest for Marketing Contract
Newsfile· 2025-12-12 19:00
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - Kingsmen Resources Ltd. (TSXV: KNG) (OTCQB: KNGRF) (FSE: TUY) ("Kingsmen" or the "Company") is pleased to announce that the Company has entered into a service agreement (the "Agreement") with Resource Stock Digest ("RSD") of Round Rock, Texas. Under the terms of the Agreement, among other things, RSD has agreed to provide certain promotional services to the Company in accordance with Policy 3.4 - Investor Relations, Promotional and Market- ...
Bird River Announces Name Change
Newsfile· 2025-12-12 18:00
Winnipeg, Manitoba--(Newsfile Corp. - December 12, 2025) - Bird River Resources Inc. (CSE: BDR) (the "Company") is pleased to announce, following the approval received from shareholders of the Company at its annual general and special meeting ("AGSM") held on November 13, 2025 and subject to the approval of the Canadian Securities Exchange (the "CSE"), the Company will complete a name change from "Bird River Resources Inc." to "Exter Gold Corp." to take effect at the open of market on or about December 17, ...
Americas Gold and Silver Completes Strategic Acquisition of the Crescent Silver Mine in Idaho
Newsfile· 2025-12-12 17:57
Core Viewpoint - Americas Gold and Silver Corporation has successfully completed the acquisition of Crescent Silver, LLC, which owns the Crescent Mine in Idaho, enhancing its operational capabilities and resource base in the region [1][2]. Acquisition Details - The acquisition consideration includes US$20 million in cash and approximately 11.1 million common shares of Americas [2]. - The Crescent Mine is strategically located just 9 miles from the Galena Complex, allowing for operational synergies [3]. Operational Strategy - The company plans to restart the Crescent Mine, which is a fully permitted past-producing mine, to provide a high-grade source of feed for the Galena Complex mills [3]. - The mineralized material at Crescent is similar to that at Galena, containing high-grade silver and potential by-products such as antimony and copper, aligning with the company's strategy to maximize production value across metals [3]. Financial Position - The company recently completed a US$132 million over-subscribed bought deal financing, which positions it well for the anticipated capital investments needed to advance Crescent into production [4]. - The company is fully funded for its growth plans and will continue its aggressive exploration drilling program across both the Crescent and Galena assets [4]. Historical Resource Information - The Crescent Mine has produced over 25 million ounces of silver at an average grade of 26 opt (891 g/t) from 1917 to 1981 [6]. - The property hosts a historical Measured and Indicated resource of 3.8 million ounces and an Inferred Resource of 19.1 million ounces [6][9]. - The 2015 Preliminary Economic Assessment (PEA) projected a production of approximately 15 million ounces of silver and 5.8 million pounds of copper over an 11-year mine life, with an average annual production of 1.4 million ounces of silver and 0.5 million pounds of copper [11]. Company Overview - Americas Gold and Silver Corporation is a growing North American mining company focused on producing silver, copper, and antimony from high-grade operations in the U.S. and Mexico [13]. - The company aims to be a leading North American silver producer and a key source of U.S.-produced antimony, with significant ownership in the Galena Complex and Cosalá Operations [13].